title: Evaluating Ebola therapies--the case for RCTs.
authors.affiliation: From the Center for Drug Evaluation and Research (E.C., R.T.) and the Office of the Commissioner (L.B.), Food and Drug Administration, Silver Spring, MD.
authors.forename: Edward
authors.initials: E
authors.lastname: Cox
authors.forename: Luciana
authors.initials: L
authors.lastname: Borio
authors.forename: Robert
authors.initials: R
authors.lastname: Temple
mesh_terms: D029043:Ebolavirus; D058872:Epidemics; D019142:Hemorrhagic Fever, Ebola / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic